|Table of Contents|

Association of copy number variation in ethanol metabolic pathway genes with susceptibility of colorectal cancer

(PDF)

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

Issue:
2018年第11期
Page:
991-997
Research Field:
临床医学
Publishing date:

Info

Title:

Association of copy number variation in ethanol metabolic pathway genes with susceptibility of colorectal cancer

Author(s):

LONG Qi CHEN Weiyan WANG Lingqiao LI Rong XIANG Menglong YANG Huan CAO Jia ZHOU Ziyuan

Department of Environment Health, Institute of Toxicology, Faculty of Military Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, 400038; Medical Company of Troop 77120, Chengdu, Sichuan Province, 610081, China

Keywords:

colorectal cancer ADH1B ALDH2 CYP2E1 copy number variation

PACS:
R195.4; R394.5; R735.3
DOI:
-
Abstract:

Objective    To investigate the relationship of the copy number variation (CNV) of 3 metabolic pathway genes for ethanol, alcohol dehydrogenase 1B (ADH1B), aldehyde dehydrogenase-2 (ALDH2) and cytochrome P450 2E1 (CYP2E1) with the susceptibility of colorectal cancer (CRC) in the population living in the Southwest China. Methods    A total of 449 CRC patients and 449 cancer-free controls were recruited during 2001 and 2004 from the 3 affiliated hospital of Army Medical University. The copy number of the 3 candidate genes were tested with a multiplex gene copy number quantitation method AccuCopyTM. Then 10% samples were further verified for the copy number. Unconditional logistic regression analysis was applied to evaluate the association between germline CNV genotypes and CRC risk. Results    There was no significant difference in the gene copy number of both ADH1B and ALDH2 between CRC patients and normal controls, and the number was 2 copies. While the copy number of CYP2E1 had significantly different distribution between the CRC patients and control subjects (P=0.046). Moreover, logistic regression analysis showed that the gain of CYP2E1 was a risk factor for CRC (OR=2.47, 95%CI: 1.04~5.85,P=0.041). A further assessment for possible modifications of surrounding factors in a stratification analysis indicated that a positive association of CYP2E1 gain and CRC risk was found in subpopulations of older than 50 years, colon cancer, and daily ethanol consumption ≤50 g. Conclusion    The gain of CYP2E1 copy number is associated with CRC in the population in the Southwest China.

References:

[1]HUGHES L A E, SIMONS C C J M, VAN DEN BRANDT P A, et al. Lifestyle, diet, and colorectal cancer risk according to(epi)genetic instability: current evidence and future directions of molecular pathological epidemiology[J]. Curr Colorectal Cancer Rep, 2017, 13(6): 455-469.DOI:10.1007/s11888-017-0395-0.
[2]ARNOLD M, SIERRA M S, LAVERSANNE M, et al. Global patterns and trends in colorectal cancer incidence and mortality[J]. Gut,2017,66(4):683-691.DOI:10.1136/gutjnl2015310912.
[3]CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin,2016,66(2): 115-132.DOI:10.3322/caac.21338.
[4]LOCONTE N K, BREWSTER A M, KAUR J S, et al. Alcohol and cancer: A statement of the American Society of Clinical Oncology[J].J Clin Oncol,2018, 36(1):83-93. DOI:10.1200/jco.2017.76.1155.
[5]SCOCCIANTI C, CECCHINI M, ANDERSON A S, et al. European code against cancer 4th edition: alcohol drinking and cancer[J].Cancer Epidemiology,2015, 39(S1):S67-S74.DOI:10.1016/j.canep.2015.01.007.
[6]WISEMAN M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective[J]. Proc Nutr Soc, 2008, 67: 253-256.
[7]BAGNARDI V, ROTA M, BOTTERI E, et al. Alcohol consumption and sitespecific cancer risk: a comprehensive doseresponse metaanalysis[J]. Br J Cancer, 2015, 112(3): 580-593.doi:10.1038/bjc.2014.579.
[8]ZAKHARI S. Overview: how is alcohol metabolized by the body?[J]. Alcohol Res Health, 2006, 29(4): 245-254.
[9]ERIKSSON C J. The role of acetaldehyde in the actions of alcohol (update 2000)[J]. Alcohol Clin Exp Res, 2001, 25(5 Suppl ISBRA): 15S-32S.
[10]YANG H, ZHOU Y, ZHOU Z, et al. A novel polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal cancer in a southwestern Chinese population[J]. Cancer Epidemiol Biomarkers Prev, 2009, 18(9): 2522-2527.DOI:10.1158/10559965.EPI090398.
[11]LICHTENSTEIN P, HOLM N V, VERKASALO P K, et al. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland[J]. N Engl J Med, 2000, 343(2):78-85. DOI:10.1056/NEJM200007133430201.
[12]CROUSBOU M, RENNERT G,CUADRAS D, et al. Polymorphisms in alcohol metabolism genes ADH1B and ALDH2, alcohol consumption and colorectal cancer[J]. PLoS ONE,2013,8(11):e80158.DOI:10.1371/journal.pone.0080158.
[13]JIANG O, ZHOU R, WU D, et al. CYP2E1 polymorphisms and colorectal cancer risk: a HuGE systematic review and metaanalysis[J]. Tumour Biol, 2013, 34(2): 1215-1224.DOI:10.1007/s13277013-0664-8.
[14]REDON R, ISHIKAWA S, FITCH K R, et al. Global variation in copy number in the human genome[J]. Nature, 2006, 444(7118): 444-454.DOI:10.1038/nature05329.
[15]STRANGER B E, FORREST M S, DUNNING M, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes[J]. Science, 2007, 315(5813): 848-853.DOI:10.1126/science.1136678.
[16]STANKIEWICZ P, LUPSKI J R. Structural variation in the human genome and its role in disease[J]. Annu Rev Med, 2010,61:437-455.DOI:10.1146/annurev-med-100708-204735.
[17]ZHANG D, LI Z, XU X, et al. Deletions at SLC18A1 increased the risk of CRC and lower SLC18A1 expression associated with poor CRC outcome[J]. Carcinogenesis, 2017, 38(11): 1057-1062.DOI:10.1093/carcin/bgx088.
[18]PARK C, KIM J I, HONG S N, et al. A copy number variation in PKD1L2 is associated with colorectal cancer predisposition in korean population[J]. Int J Cancer, 2017, 140(1): 86-94.DOI:10.1002/ijc.30421.
[19]DU R, LU C, JIANG Z, et al. Efficient typing of copy number variations in a segmental duplicationmediated rearrangement hotspot using multiplex competitive amplification[J]. J Hum Genet, 2012, 57(8): 545-551.DOI:10.1038/jhg.2012.66.
[20]SAEED H M, ALANAZI M S, NOUNOU H A, et al. Cytochrome P450 1A1, 2E1 and GSTM1 gene polymorphisms and susceptibility to colorectal cancer in the Saudi population[J]. Asian Pac J Cancer Prev, 2013, 14(6): 3761-3768.
[21]ZHOU G W, HU J, LI Q. CYP2E1 PstⅠ/RsaⅠ polymorphism and colorectal cancer risk: a metaanalysis[J]. World J Gastroenterol, 2010, 16(23): 2949-2953.DOI:10.3748/wjg.v16.i23.2949.
[22]PENG H, XIE S K, HUANG M J, et al. Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and metaanalysis[J].Tumour Biol, 2013, 34(4): 2389-2395.DOI:10.1007/s13277-013-0788-x.
[23]QIAN J, SONG Z, LV Y, et al. CYP2E1 T7632A and 9bp insertion polymorphisms and colorectal cancer risk: a metaanalysis based on 4 592 cases and 5 918 controls[J].Tumour Biol,2013, 34(4): 2225-2231.DOI:10.1007/s13277-013-0762-7.
[24]HARAKSINGH R R, SNYDER M P. Impacts of variation in the human genome on gene regulation[J]. J Mol Biol, 2013, 425(21): 3970-3977. DOI:10.1016/j.jmb.2013.07.015.
[25]MELKONIAN S C, WANG X, GU J, et al. Mitochondrial DNA copy number in peripheral blood leukocytes and the risk of clear cell renal cell carcinoma[J]. Carcinogenesis, 2015, 36(2): 249-255. DOI:10.1093/carcin/bgu248.
[26]YU K, FAN J, DING X, et al. Association study of a functional copy number variation in the WWOX gene with risk of gliomas among Chinese people[J]. Int J Cancer, 2014, 135(7): 1687-1691.DOI:10.1002/ijc.28815.
[27]BI H, TIAN T, ZHU L, et al. Copy number variation of E3 ubiquitin ligase genes in peripheral blood leukocyte and colorectal cancer[J]. Sci Rep, 2016, 6:29869.DOI:10.1038/srep29869.
[28]SEITZ H K, STICKEL F. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress[J]. Biol Chem, 2006, 387(4): 349-360.DOI:10.1515/BC.2006.047.
[29]BADGER T M, RONIS M J, SEITZ H K, et al. Alcohol metabolism: role in toxicity and carcinogenesis[J]. Alcohol Clin Exp Res, 2003, 27(2): 336-347.DOI:10.1097/01.ALC.0000052583.87673.37.
[30]PERERA R M, BARDEESY N. Cancer: when antioxidants are bad[J]. Nature, 2011, 475(7354): 43-44.DOI:10.1038/475043a.
[31]SANCHEZALVAREZ R, MARTINEZOUTSCHOORN U E, LIN Z, et al. Ethanol exposure induces the cancerassociated fibroblast phenotype and lethal tumor metabolism: implications for breast cancer prevention[J]. Cell Cycle, 2013, 12(2): 289-301.DOI:10.4161/cc.23109.
[32]WANG F, YANG J L, YU K K, et al. Activation of the NFκB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma[J]. Mol Cancer, 2015, 14:10.DOI:10.1186/s1294301402740.
[33]MYANT K B, CAMMARERI P, MCGHEE E J, et al. ROS production and NFkappaB activation triggered by RAC1 facilitate WNTdriven intestinal stem cell proliferation and colorectal cancer initiation[J]. Cell Stem Cell, 2013, 12(6): 761-773.DOI:10.1016/j.stem.2013.04.006.
[34]FILAIRE E, DUPUIS C, GALVAING G, et al. Lung cancer: what are the links with oxidative stress, physical activity and nutrition[J]. Lung Cancer, 2013, 82(3): 383-389.DOI:10.1016/j.lungcan.2013.09.009.
[35]PASCHOS A, PANDYA R, DUIVENVOORDEN W C, et al. Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics[J]. Prostate Cancer Prostatic Dis, 2013, 16(3): 217-225.DOI:10.1038/pcan.2013.13.
[36]KOEHLER B C, ARSLICSCHMITT T, PECCERELLA T, et al. Possible mechanisms of ethanolmediated colorectal carcinogenesis: the role of cytochrome P4502E1, ethenoDNA adducts, and the antiapoptotic protein Mcl1[J]. Alcohol Clin Exp Res, 2016, 40(10): 2094-2101.DOI:10.1111/acer.13180.
[37]GINSBERG G, SMOLENSKI S, NEAFSEY P, et al. The influence of genetic polymorphisms on population variability in six xenobioticmetabolizing enzymes[J]. J Toxicol Environ Health B Crit Rev,2009,12(5/6):307-333. DOI:10.1080/10937400903158318.
[38]HU L, WU Y, GUAN X, et al. Germline copy number loss of UGT2B28 and gain of PLEC contribute to increased human esophageal squamous cell carcinoma risk in Southwest China[J]. Am J Cancer Res, 2015, 5(10): 3056-3071.
[39]LIU B, YANG L, HUANG B, et al. A functional copynumber variation in MAPKAPK2 predicts risk and prognosis of lung cancer[J]. Am J Hum Genet, 2012, 91(2): 384-390.DOI:10.1016/j.ajhg.2012.07.003.

Memo

Memo:
-
Last Update: 2018-06-14